A caveat with the hypothesis that increased extracellular NE might be driving DSP-4-mediated neuroprotection is that this fails to explain why DSP-4 pretreatment is not neuroprotective in other mouse models of PD, like the 6OHDA and LPS mouse model of PD [4–6]. This evidence concerns the gene DUSP26 and Parkinson disease.